| Product Code: ETC5821282 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Cyprus biologics import market continues to experience significant growth, with key exporting countries including Metropolitan France, Belgium, Denmark, UK, and USA. The market concentration, as measured by the HHI, has intensified from high to very high in 2024, indicating a more consolidated market landscape. The impressive CAGR of 110.54% from 2020 to 2024 reflects the increasing demand for biologics in Cyprus. Moreover, the notable growth rate of 52.24% from 2023 to 2024 signals a rapid acceleration in import shipments, highlighting the country's growing reliance on biologics from these top exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Biologics Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Biologics Market - Industry Life Cycle |
3.4 Cyprus Biologics Market - Porter's Five Forces |
3.5 Cyprus Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Cyprus Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Cyprus Biologics Market Revenues & Volume Share, By Disease? Category, 2021 & 2031F |
3.8 Cyprus Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2021 & 2031F |
4 Cyprus Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Biologics Market Trends |
6 Cyprus Biologics Market Segmentations |
6.1 Cyprus Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Biologics Market Revenues & Volume, By Microbial, 2021-2031F |
6.1.3 Cyprus Biologics Market Revenues & Volume, By Mammalian, 2021-2031F |
6.1.4 Cyprus Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.2 Cyprus Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.2.3 Cyprus Biologics Market Revenues & Volume, By Vaccines, 2021-2031F |
6.2.4 Cyprus Biologics Market Revenues & Volume, By Recombinant Proteins, 2021-2031F |
6.2.5 Cyprus Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2021-2031F |
6.2.6 Cyprus Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.3 Cyprus Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Biologics Market Revenues & Volume, By Oncology, 2021-2031F |
6.3.3 Cyprus Biologics Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.3.4 Cyprus Biologics Market Revenues & Volume, By Immunological Disorders, 2021-2031F |
6.3.5 Cyprus Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2021-2031F |
6.3.6 Cyprus Biologics Market Revenues & Volume, By Hematological Disorders, 2021-2031F |
6.3.7 Cyprus Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.4 Cyprus Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Biologics Market Revenues & Volume, By Outsourced, 2021-2031F |
6.4.3 Cyprus Biologics Market Revenues & Volume, By In-house, 2021-2031F |
7 Cyprus Biologics Market Import-Export Trade Statistics |
7.1 Cyprus Biologics Market Export to Major Countries |
7.2 Cyprus Biologics Market Imports from Major Countries |
8 Cyprus Biologics Market Key Performance Indicators |
9 Cyprus Biologics Market - Opportunity Assessment |
9.1 Cyprus Biologics Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Cyprus Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Cyprus Biologics Market Opportunity Assessment, By Disease? Category, 2021 & 2031F |
9.4 Cyprus Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2021 & 2031F |
10 Cyprus Biologics Market - Competitive Landscape |
10.1 Cyprus Biologics Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here